Long-Term Benefits of N-Butylphthalide in Preventing Ischemic Stroke Recurrence: A 12-Month Prospective Study
Open Access
- 1 May 2025
- journal article
- research article
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 21, 781-792
Abstract
Purpose: This study evaluated the effects of 12 months of NBP treatment on stroke recurrence and examined the influence of age and gender on its efficacy. Methods: A prospective cohort of 1109 patients with non-cardioembolic ischemic stroke (IS) within six months was divided into NBP (n = 538) and control (n = 571) groups. The NBP group received NBP plus standard treatment, while the control group received standard treatment alone. Primary outcomes were recurrent ischemic and hemorrhagic stroke over 12 months. Secondary outcomes included functional status (modified Rankin Scale, m-RS) and all-cause mortality. Results: NBP reduced recurrent IS by 39% compared to controls (RR:0.61,95% CI:0.40– 0.93, P=0.022) and total stroke events by 39.6% (RR:0.60,95% CI:0.40– 0.91,P=0.016). Protective effects were more significant in males (RR:0.52,95% CI:0.30– 0.91, P=0.021 vs RR:0.53,95% CI:0.40– 0.91,P=0.021) and in patients under 70 years (P< 0.05). Functional outcomes (modified Rankin Scale and Barthel index) and all-cause mortality did not differ significantly between groups (all P> 0.05). Conclusion: NBP significantly reduces stroke recurrence and overall vascular events, especially in males and younger patients. While it does not improve functional outcomes or mortality, NBP demonstrates substantial preventive value for recurrent strokes.Keywords
This publication has 37 references indexed in Scilit:
- DL-3-n-butylphthalide improves the endothelium-dependent vasodilation in high-fat diet-fed ApoE−/− mice via suppressing inflammation, endothelial necroptosis and apoptosisEuropean Journal of Pharmacology, 2023
- Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic StrokeJAMA Neurology, 2023
- Trends and Risk Factors Associated With Stroke Recurrence in China, 2007-2018JAMA Network Open, 2022
- Age-associated alterations in immune function and inflammationProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2022
- DL-3-n-butylphthalide prevents oxidative stress and atherosclerosis by targeting Keap-1 and inhibiting Keap-1/Nrf-2 interactionEuropean Journal of Pharmaceutical Sciences, 2022
- Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019The Lancet Public Health, 2021
- Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Neurology, 2021
- New Horizons in Pharmacologic Therapy for Secondary Stroke PreventionJAMA Neurology, 2020
- Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adultsThe Lancet Global Health, 2020
- Sex differences in the evaluation and treatment of acute ischaemic strokeThe Lancet Neurology, 2018